Red blood cells from pluripotent stem cells for use in transfusion

Mountford, J.C., Olivier, E., Jordanides, N. E., de Sousa, P. and Turner, M. L. (2010) Red blood cells from pluripotent stem cells for use in transfusion. Regenerative Medicine, 5(3), pp. 411-423. (doi:10.2217/rme.10.22)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.2217/rme.10.22

Abstract

The use of donated red blood cells in transfusion is a well-established cellular therapy. However, problems including insufficient supply, transfusion-transmitted infections and the need for immunological matching hamper even in the best services. These issues may be eliminated by using pluripotent stem cells to generate universal donor group O, Rhesus D-negative red blood cells. Human embryonic stem cells can be maintained and expanded indefinitely and can, therefore, produce the very large cell numbers required for this application. Red blood cell production is also an attractive goal for pluripotent stem cell-derived therapeutics because it is a well-characterized single cell suspension, lacking nucleated cells and with a low expression of HLA molecules. Much progress has been made; however, a number of challenges remain including scale-up, clinical effectiveness and product safety.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Mountford, Dr Joanne and Olivier, Dr Emmanuel
Authors: Mountford, J.C., Olivier, E., Jordanides, N. E., de Sousa, P., and Turner, M. L.
College/School:College of Medical Veterinary and Life Sciences > Institute of Neuroscience and Psychology
College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:Regenerative Medicine
ISSN:1746-0751

University Staff: Request a correction | Enlighten Editors: Update this record